Tradestie Institutional Equity Comparison Engine

CVM vs FBRX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

FBRX Overall Edge

FBRX Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Forte Biosciences, Inc. Common Stock (FBRX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while CVM counters with relative strength in Valuation. Fundamentally, CVM trades at 23.0x Forward P/E with 0.0% operating margin (-62.7% YoY revenue) versus FBRX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CVM sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against FBRX sits in UNCLASSIFIED (3rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CVM
CVM 23.0x vs FBRX N/M Fwd P/E
Growth & Margin Winner FBRX
Op Margin 0.0% vs 0.0% ยท YoY -62.7% vs +0.0%
Momentum & Technical Winner FBRX
1Y -77.5% vs +580.4% ยท 52W Pos 10% vs 100%
Options & Structure Winner FBRX
BREAKDOWN (N/A IV) vs UNCLASSIFIED (3rd %ile IV)
CVM NYSE American
Cel-Sci Corporation
Biological Products, (No Disgnostic Substances)
$1.59
+24.22% 1D
Market Cap $20.9M
1M Return -11.17%
1Y Return -77.48%
Forward P/E 23.0x
Unified AI Score
56.6 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 50.0 Mom 60.0
FBRX NASDAQ
Forte Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$76.99
+0.03% 1D
Market Cap $1.6B
1M Return +0.44%
1Y Return +580.42%
Forward P/E N/M
Unified AI Score
52.7 / 100 HOLD
Tech 49.0 Fund 51.0 Flow 62.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CVM -77.48% FBRX +580.42% Spread: +682.88 pp (FBRX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CVM Revenue FBRX Revenue CVM Op. Margin FBRX Op. Margin Margin Edge
FY2011 $0M N/A -1881.0% N/A CVM
FY2012 $0M N/A -6772.3% N/A CVM
FY2013 $0M N/A -12450.1% N/A CVM
FY2014 $0M N/A -9721.4% N/A CVM
FY2016 N/A $0M N/A -64673.5% FBRX
FY2017 N/A $0M N/A -91775.6% FBRX
FY2018 N/A $20M N/A -254.2% FBRX
FY2019 N/A $0M N/A -11288.9% FBRX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CVM (3) vs FBRX (5)
Institutional Metric CVM FBRX Criterion Row Winner
Market Capitalization Scale $20.9M $1.6B Larger Scale FBRX
Trailing P/E Ratio Valuation 23.0x N/M Lower Multiple CVM
Forward P/E Ratio Valuation 23.0x N/M Lower Multiple CVM
Revenue Growth (YoY) Growth -62.7% +0.0% Higher Growth FBRX
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -252.5% -62.3% Higher ROE FBRX
52-Week Range Position Momentum 10% ($1โ€“$8) 100% ($10โ€“$77) Stronger Trend FBRX
Beta / 30D Volatility Risk Regime 0.65ฮฒ ยท 120% Vol 1.09ฮฒ ยท 3% Vol Lower Realized Risk FBRX
Unified Institutional Score Composite Signal 56.6 / 100 (HOLD) 52.7 / 100 (HOLD) Higher Composite CVM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CVM vs FBRX Buy Guide
CVM BREAKDOWN
29d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CVM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FBRX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live FBRX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CVM nor FBRX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.